A multipurpose prevention technology (MPT) that combines HIV and pregnancy prevention is a promising women’s health intervention, particularly for young women. However, little is known about the drivers of acceptability and product choice for MPTs in this population. This paper explores approval ratings and stated choice across three different MPT delivery forms among potential end-users. The Trio Study was a mixed-methods study in women ages 18–30 that examined acceptability of three MPT delivery forms: oral tablets, injections, and vaginal ring. Approval ratings and stated choice among the products was collected at baseline. Factors influencing stated product choice were explored using multivariable multinomial logistic regression. The majority (62%) of women in Trio stated they would choose injections, 27% would choose tablets and 11% would choose the ring. Significant predictors of choice included past experience with similar contraceptive delivery forms, age, and citing frequency of use as important. Ring choice was higher for older (25–30) women than for younger (18–24) women (aRR = 3.1; p < 0.05). These results highlight the importance of familiarity in MPT product choice of potential for variations in MPT preference by age.
End-users’ product preference across three multipurpose prevention technology delivery forms
Baseline results from young women in Kenya and South Africa
Weinrib, R., Minnis, A., Agot, K., Ahmed, K., Owino, F., Manenzhe, K., Cheng, H., & van der Straten, A. (2018). End-users’ product preference across three multipurpose prevention technology delivery forms: Baseline results from young women in Kenya and South Africa. AIDS and Behavior, 22(1), 133-145. https://doi.org/10.1007/s10461-017-1911-6